Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions

J. G. Schwartz, Carlos Bazan Iii, C. L. Gage, T. J. Prihoda, S. L. Gillham

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We divided patients with brain lesions into three groups: (a) patients with primary or metastatic brain cancer, (b) brain infarctions, and (c) brain contusion(s). We analyzed each patient's sera for creatine kinase isoenzyme BB (CK-BB), using a monoclonal antibody kit (Impres-BB; International Immunoassay Laboratories). Computerized axial tomography (CAT) scans were performed on each patient. The size of the various lesions was measured from the CAT scan and recorded in milliliters. Total CK, CK-BB, and their ratios were compared with the volume of damaged brain tissue. We found no correlation between any of the variables and the various brain lesions. We attribute this lack of correlation to an intact blood-brain barrier, the rapid elimination or inactivation of CK-BB, or some combination of these factors.

Original languageEnglish (US)
Pages (from-to)651-654
Number of pages4
JournalClinical Chemistry
Volume35
Issue number4
StatePublished - 1989

Fingerprint

BB Form Creatine Kinase
Creatine Kinase
Isoenzymes
Brain
Serum
Brain Neoplasms
Tomography
Brain Infarction
Blood-Brain Barrier
Immunoassay
Monoclonal Antibodies
Tissue

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Schwartz, J. G., Bazan Iii, C., Gage, C. L., Prihoda, T. J., & Gillham, S. L. (1989). Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions. Clinical Chemistry, 35(4), 651-654.

Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions. / Schwartz, J. G.; Bazan Iii, Carlos; Gage, C. L.; Prihoda, T. J.; Gillham, S. L.

In: Clinical Chemistry, Vol. 35, No. 4, 1989, p. 651-654.

Research output: Contribution to journalArticle

Schwartz, JG, Bazan Iii, C, Gage, CL, Prihoda, TJ & Gillham, SL 1989, 'Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions', Clinical Chemistry, vol. 35, no. 4, pp. 651-654.
Schwartz JG, Bazan Iii C, Gage CL, Prihoda TJ, Gillham SL. Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions. Clinical Chemistry. 1989;35(4):651-654.
Schwartz, J. G. ; Bazan Iii, Carlos ; Gage, C. L. ; Prihoda, T. J. ; Gillham, S. L. / Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions. In: Clinical Chemistry. 1989 ; Vol. 35, No. 4. pp. 651-654.
@article{04c1d6507c3747899aa08ca2733c7773,
title = "Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions",
abstract = "We divided patients with brain lesions into three groups: (a) patients with primary or metastatic brain cancer, (b) brain infarctions, and (c) brain contusion(s). We analyzed each patient's sera for creatine kinase isoenzyme BB (CK-BB), using a monoclonal antibody kit (Impres-BB; International Immunoassay Laboratories). Computerized axial tomography (CAT) scans were performed on each patient. The size of the various lesions was measured from the CAT scan and recorded in milliliters. Total CK, CK-BB, and their ratios were compared with the volume of damaged brain tissue. We found no correlation between any of the variables and the various brain lesions. We attribute this lack of correlation to an intact blood-brain barrier, the rapid elimination or inactivation of CK-BB, or some combination of these factors.",
author = "Schwartz, {J. G.} and {Bazan Iii}, Carlos and Gage, {C. L.} and Prihoda, {T. J.} and Gillham, {S. L.}",
year = "1989",
language = "English (US)",
volume = "35",
pages = "651--654",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "4",

}

TY - JOUR

T1 - Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions

AU - Schwartz, J. G.

AU - Bazan Iii, Carlos

AU - Gage, C. L.

AU - Prihoda, T. J.

AU - Gillham, S. L.

PY - 1989

Y1 - 1989

N2 - We divided patients with brain lesions into three groups: (a) patients with primary or metastatic brain cancer, (b) brain infarctions, and (c) brain contusion(s). We analyzed each patient's sera for creatine kinase isoenzyme BB (CK-BB), using a monoclonal antibody kit (Impres-BB; International Immunoassay Laboratories). Computerized axial tomography (CAT) scans were performed on each patient. The size of the various lesions was measured from the CAT scan and recorded in milliliters. Total CK, CK-BB, and their ratios were compared with the volume of damaged brain tissue. We found no correlation between any of the variables and the various brain lesions. We attribute this lack of correlation to an intact blood-brain barrier, the rapid elimination or inactivation of CK-BB, or some combination of these factors.

AB - We divided patients with brain lesions into three groups: (a) patients with primary or metastatic brain cancer, (b) brain infarctions, and (c) brain contusion(s). We analyzed each patient's sera for creatine kinase isoenzyme BB (CK-BB), using a monoclonal antibody kit (Impres-BB; International Immunoassay Laboratories). Computerized axial tomography (CAT) scans were performed on each patient. The size of the various lesions was measured from the CAT scan and recorded in milliliters. Total CK, CK-BB, and their ratios were compared with the volume of damaged brain tissue. We found no correlation between any of the variables and the various brain lesions. We attribute this lack of correlation to an intact blood-brain barrier, the rapid elimination or inactivation of CK-BB, or some combination of these factors.

UR - http://www.scopus.com/inward/record.url?scp=0024588332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024588332&partnerID=8YFLogxK

M3 - Article

C2 - 2702750

AN - SCOPUS:0024588332

VL - 35

SP - 651

EP - 654

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 4

ER -